Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.

Anionic surfactants significantly improve the foaming of minoxidil gel shampoo.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Rituximab can cause skin issues, but baricitinib may help improve them.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Rituximab may cause skin issues, but baricitinib can help improve them.

Upadacitinib improved multiple immune-related conditions in one patient.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

A new tool simplifies alopecia areata severity scoring but needs validation.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.